Validity of the flap risk score in predicting nasoseptal flap use after endoscopic transsphenoidal pituitary mass resection
- PMID: 38444874
- PMCID: PMC10914567
- DOI: 10.1016/j.wnsx.2024.100330
Validity of the flap risk score in predicting nasoseptal flap use after endoscopic transsphenoidal pituitary mass resection
Abstract
Introduction: There remains a paucity of literature examining the decision algorithm for use of nasoseptal flap (NSF) after endoscopic endonasal approaches (EEA) to pituitary adenoma resection. In 2018, we published the first ever flap risk score (FRS) to predict the use of NSF. We present here a validity study examining the FRS as applied to our center.
Methods: A retrospective review was completed of consecutive patients undergoing EEA from January 2015 to March 2021. The sensitivity, specificity, and predictive value of the FRS were calculated. A multivariate logistic model was used to determine the relative weight imaging characteristics in predicting need for NSF. The relative weighting of the FRS was then re-optimized.
Results: A total of 376 patients underwent EEA for pituitary adenoma resection, with 113 (30.1%) requiring NSF. The FRS had a sensitivity and specificity of 43.4% and 94.7%, respectively. Sphenoid sinus extension increased the odds of needing a NSF equivalent to 19 mm of tumor height, as opposed to 6 mm in the original 2018 cohort. The re-optimized model had sensitivity and specificity of 79.6% and 76.4%, respectively.
Conclusion: We present a validity study examining the utility of FRS in predicting the use of NSF after EEA for pituitary adenoma resection. Our results show that while FRS is still predictive of the need for NSF after EEA, it is not as predictive now as it was for its original cohort. Therefore, a more comprehensive model is necessary to more accurately stratify patients' preoperative risk for NSF.
Keywords: Endoscopic endonasal surgery; Nasoseptal flap; Pituitary adenoma; Transsphenoidal surgery; Validity.
© 2024 The Authors.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures
Similar articles
-
Predictors of Nasoseptal Flap Use After Endoscopic Transsphenoidal Pituitary Mass Resection.World Neurosurg. 2019 Apr;124:e356-e364. doi: 10.1016/j.wneu.2018.12.097. Epub 2018 Dec 30. World Neurosurg. 2019. PMID: 30599246
-
Nasoseptal flap necrosis: a rare complication of endoscopic endonasal surgery.J Neurosurg. 2018 May;128(5):1463-1472. doi: 10.3171/2017.2.JNS161582. Epub 2017 Jul 21. J Neurosurg. 2018. PMID: 28731395
-
Modified Nasoseptal Rescue Flap Technique for Pituitary Adenoma Resection via Endoscopic Endonasal Approach.J Craniofac Surg. 2021 Jul-Aug 01;32(5):1898-1900. doi: 10.1097/SCS.0000000000007621. J Craniofac Surg. 2021. PMID: 33710052
-
Endoscopic Endonasal Approach for Craniopharyngiomas with Intraventricular Extension: Case Series, Long-Term Outcomes, and Review.World Neurosurg. 2020 Dec;144:e447-e459. doi: 10.1016/j.wneu.2020.08.184. Epub 2020 Sep 2. World Neurosurg. 2020. PMID: 32890848 Review.
-
The Value of Intraoperative Magnetic Resonance Imaging in Endoscopic Endonasal Resection of Pituitary Adenoma.J Neurol Surg B Skull Base. 2022 Sep 28;83(6):646-652. doi: 10.1055/a-1924-8166. eCollection 2022 Dec. J Neurol Surg B Skull Base. 2022. PMID: 36393881 Free PMC article. Review.
References
-
- Hannan C.J., Almhanedi H., Al-Mahfoudh R., Bhojak M., Looby S., Javadpour M. Predicting post-operative cerebrospinal fluid (CSF) leak following endoscopic transnasal pituitary and anterior skull base surgery: a multivariate analysis. Acta Neurochir. 2020;162(6):1309–1315. doi: 10.1007/s00701-020-04334-5. - DOI - PubMed
LinkOut - more resources
Full Text Sources